NCT01564628

Brief Summary

The purpose of the study is to optimize an already existing algorithm for diagnosing atherosclerosis of the coronary arteries (CAD, Coronary Artery Disease).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
306

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2012

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2012

Completed
20 days until next milestone

First Submitted

Initial submission to the registry

March 21, 2012

Completed
7 days until next milestone

First Posted

Study publicly available on registry

March 28, 2012

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2013

Completed
5.9 years until next milestone

Results Posted

Study results publicly available

August 19, 2019

Completed
Last Updated

August 19, 2019

Status Verified

July 1, 2019

Enrollment Period

1.6 years

First QC Date

March 21, 2012

Results QC Date

March 14, 2019

Last Update Submit

July 15, 2019

Conditions

Keywords

CAD

Outcome Measures

Primary Outcomes (1)

  • The Area Under the Receiver Operating Characteristic Curve of the CAD-score to Separate CAD From Non-CAD Patients.

    Cardiac noise marker (CAD-score) ability to separate CAD from non-CAD patients is estimated as the area under the receiver operating characteristic curve. The area under the receiver operating characteristic curve is plottet as sensitivity versus 1-specificity as a function of different CAD-score cut-off values. The area under the receiver operating characteristic curve is on a scale from 0-100%, the higher value means a better separation of CAD from non-CAD patients. CAD and non-CAD patients are defined by the CTA and CAG evaluations.

    Heart sound recordings measured on testday (25 minutes study period)

Study Arms (1)

All study participants

Population from 2 sites, sequential design with all patients undergoing CADScor1 intervention followed by the diagnostic testing the patients were referred to (procedure done according to standard of care and not part of study; computerized tomographic angiography (CTA) and, if relevant, coronary angiography (CAG) at Site 1 and CAG at site 2).

Device: CADScor1

Interventions

CADScor1DEVICE

Acoustic recording

All study participants

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients referred to examination for Coronary Artery Disease

You may qualify if:

  • At least 18 years old
  • Referred to diagnostically Ca-CT, CT scan and/or CAG examination due to suspicion of coronary artery disease
  • Subjects condition must be stable and the subject must not be referred due to suspicion of acute coronary syndrome
  • Subject is willing to adhere to the study procedure
  • Has signed the informed consent form and authorization to registration and publication of health information

You may not qualify if:

  • Has acute coronary syndrome or stroke
  • Arterial fibrillation
  • Known severe arrhythmia or resting heart rate above 85 bpm
  • Known diastolic murmurs due to heart valve disease
  • Has had a previous by-pass operation, open chest surgery, donor heart or mechanical heart
  • Reduced ejection fraction \< 50%
  • Inability to understand or adhere to instructions for acoustic Data-acquisition (i.e. subject not able to hold breath due to KOL or asthma)
  • Inability to perform CT-angio and/or subsequent CAG
  • In active treatment for any cancer
  • In active treatment for immunosuppression after transplantation
  • Established or pursuing pregnancy or breast feeding
  • Has damaged skin on the spot where the patch is placed during the recordings.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital of Aarhus, Skejby

Aarhus N, 8200, Denmark

Location

MeSH Terms

Conditions

Coronary Artery Disease

Condition Hierarchy (Ancestors)

Coronary DiseaseMyocardial IschemiaHeart DiseasesCardiovascular DiseasesArteriosclerosisArterial Occlusive DiseasesVascular Diseases

Results Point of Contact

Title
Claus Christensen
Organization
Acarix A/S

Study Officials

  • Morten Bøttcher, MD

    University Hospital of Aarhus, Skejby

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restriction Type
LTE60
Restrictive Agreement
Yes

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 21, 2012

First Posted

March 28, 2012

Study Start

March 1, 2012

Primary Completion

October 1, 2013

Study Completion

October 1, 2013

Last Updated

August 19, 2019

Results First Posted

August 19, 2019

Record last verified: 2019-07

Locations